Acurx Pharmaceuticals (ACXP) to Release Earnings on Wednesday

Acurx Pharmaceuticals (NASDAQ:ACXP) will be announcing its earnings results before the market opens on Wednesday, November 13th. Analysts expect the company to announce earnings of ($0.23) per share for the quarter. Individual interested in registering for the company’s earnings conference call can do so using this link.

Acurx Pharmaceuticals (NASDAQ:ACXP) last announced its earnings results on Friday, August 9th. The company reported ($0.26) earnings per share for the quarter, beating the consensus estimate of ($0.28) by $0.02. During the same period in the prior year, the firm posted ($0.28) EPS. On average, analysts expect Acurx Pharmaceuticals to post $-1 EPS for the current fiscal year and $-2 EPS for the next fiscal year.

Acurx Pharmaceuticals Stock Performance

Shares of Acurx Pharmaceuticals stock opened at $1.85 on Wednesday. Acurx Pharmaceuticals has a 52 week low of $1.52 and a 52 week high of $5.28. The stock has a market cap of $30.06 million, a PE ratio of -1.57 and a beta of -1.73. The company’s 50-day moving average price is $2.01 and its two-hundred day moving average price is $2.15.

Wall Street Analysts Forecast Growth

Separately, HC Wainwright reissued a “buy” rating and set a $12.00 target price on shares of Acurx Pharmaceuticals in a research note on Monday, August 12th.

Acurx Pharmaceuticals Company Profile

Acurx Pharmaceuticals, Inc, a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. The company's lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that is in Phase 2b clinical trial to treat patients with clostridium difficile infections.